Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
ACS Chem Neurosci ; 15(14): 2612-2622, 2024 Jul 17.
Artículo en Inglés | MEDLINE | ID: mdl-38925635

RESUMEN

Numerous insults, both endogenous (e.g., glutamate) and exogenous (e.g., pesticides), compromise the function of the nervous system and pose risk factors for damage or later disease. In previous reports, limonoids such as fraxinellone showed significant neuroprotective activity against glutamate (Glu) excitotoxicity and reactive oxygen species (ROS) production in vitro, albeit with minimal mechanistic information provided. Given these findings, a library of novel fraxinellone analogs (including analogs 1 and 2 described here) was synthesized with the goal of identifying compounds exhibiting neuroprotection against insults. Analog 2 was found to be protective against Glu-mediated excitotoxicity with a measured EC50 of 44 and 39 nM for in vitro assays using PC12 and SH-SY5Y cells, respectively. Pretreatment with analog 2 yielded rapid induction of antioxidant genes, namely, Gpx4, Sod1, and Nqo1, as measured via qPCR. Analog 2 mitigated Glu-mediated ROS. Cytoprotection could be replicated using sulforaphane (SFN), a Nrf2 activator, and inhibited via ML-385, which inhibits Nrf2 binding to regulatory DNA sequences, thereby blocking downstream gene expression. Nrf2 DNA-binding activity was demonstrated using a Nrf2 ELISA-based transcription factor assay. In addition, we found that pretreatment with the thiol N-acetyl Cys completely mitigated SFN-mediated induction of antioxidant genes but had no effect on the activity of analog 2, suggesting thiol modification is not critical for its mechanism of action. In summary, our data demonstrate a fraxinellone analog to be a novel, potent, and rapid activator of the Nrf2-mediated antioxidant defense system, providing robust protection against insults.


Asunto(s)
Ácido Glutámico , Fármacos Neuroprotectores , Especies Reactivas de Oxígeno , Fármacos Neuroprotectores/farmacología , Humanos , Animales , Especies Reactivas de Oxígeno/metabolismo , Ratas , Células PC12 , Ácido Glutámico/metabolismo , Factor 2 Relacionado con NF-E2/metabolismo , Antioxidantes/farmacología , Línea Celular Tumoral , Isotiocianatos/farmacología , Dioxolanos/farmacología , Benzofuranos , Sulfóxidos
2.
ACS Catal ; 14(6): 4093-4098, 2024 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-38510665

RESUMEN

While substituted adamantanes have widespread use in medicinal chemistry, materials science, and ligand design, the use of diamantanes and higher diamondoids is limited to a much smaller number. Selective functionalization beyond adamantane is challenging, as the number of very similar types of C-H bonds (secondary, 2°, and tertiary, 3°) increases rapidly, and H atom transfer does not provide a general solution for site selectivity. We report a method using pyrylium photocatalysts that is effective for nanodiamond functionalization in up to 84% yield with exclusive 3° selectivity and moderate levels of regioselectivity between 3° sites. The proposed mechanism involving photooxidation, deprotonation, and radical C-C bond formation is corroborated through Stern-Volmer luminescence quenching, cyclic voltammetry, and EPR studies. Our photoredox strategy offers a versatile approach for the streamlined synthesis of diamondoid building blocks.

3.
Pers Individ Dif ; 207: 112155, 2023 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-36923243

RESUMEN

Throughout the COVID-19 pandemic, attention has been drawn to conspiracy theories. To date, research has largely examined commonalities in conspiracy theory belief, however it is important to identify where there may be notable differences. The aim of the present research was first to distinguish between typologies of COVID-19 conspiracy belief and explore demographic, social cognitive factors associated with these beliefs. Secondly, we aimed to examine the effects of such beliefs on adherence to government health guidelines. Participants (N = 319) rated well known COVID-19 conspiracy theories, completing measures of thinking style, socio-political control, mistrust, verbal intelligence, need for closure and demographic information. Participants also rated the extent to which they followed government health guidelines. Latent profile analysis suggests three profiles of COVID-19 conspiracy beliefs with low, moderate, and high COVID conspiracy belief profiles and successively stronger endorsement on all but one of the COVID-19 conspiracy theories. Those holding stronger COVID-19 conspiracy theory beliefs are more likely to reason emotively, feel less socio-political control, mistrust others, have lower verbal ability and adhere less to COVID-19 guidelines. The social and health implications of these findings are discussed.

4.
Org Biomol Chem ; 20(1): 10-36, 2021 12 22.
Artículo en Inglés | MEDLINE | ID: mdl-34651636

RESUMEN

Adamantane derivatives have diverse applications in the fields of medicinal chemistry, catalyst development and nanomaterials, owing to their unique structural, biological and stimulus-responsive properties, among others. The synthesis of substituted adamantanes and substituted higher diamondoids is frequently achieved via carbocation or radical intermediates that have unique stability and reactivity when compared to simple hydrocarbon derivatives. In this review, we discuss the wide range of radical-based functionalization reactions that directly convert diamondoid C-H bonds to C-C bonds, providing a variety of products incorporating diverse functional groups (alkenes, alkynes, arenes, carbonyl groups, etc.). Recent advances in the area of selective C-H functionalization are highlighted with an emphasis on the H-atom abstracting species and their ability to activate the particularly strong C-H bonds that are characteristic of these caged hydrocarbons, providing insights that can be applied to the C-H functionalization of other substrate classes.

5.
Environ Sci Technol ; 55(10): 6700-6709, 2021 05 18.
Artículo en Inglés | MEDLINE | ID: mdl-33913707

RESUMEN

α-Pinene ozonolysis is a key process that impacts the formation of new particles and secondary organic aerosol (SOA) in the atmosphere. The mechanistic understanding of this chemistry has been inconclusive despite extensive research, hindering accurate simulations of atmospheric processes. In this work, we examine the ozonolysis of two synthesized unsaturated carbonyl isomers (C11H18O) which separately produce the two Criegee intermediates (CIs) that would form simultaneously in α-pinene ozonolysis. Direct gas-phase measurements of peroxy radicals (RO2) from flowtube ozonolysis experiments by an iodide-adduct chemical ionization mass spectrometer suggest that the initial C10H15O4· RO2 from the CI with a terminal methyl ketone undergo autoxidation 20-fold faster than the CI with a terminal aldehyde and always outcompete the bimolecular reactions under typical laboratory and atmospheric conditions. These results provide experimental constraints on the detailed RO2 autoxidation mechanisms for understanding new particle formation in the atmosphere. Further, isomer-resolved characterization of the SOA formed from a continuous-flow stirred tank reactor using ion mobility spectrometry mass spectrometry suggests that the two structurally different CIs predominantly and unexpectedly form constituents with identical structures. These results open up possibilities of diverse isomerization pathways that the two CIs may undergo that form mutual products to a large extent toward their way forming the SOA. This work highlights new insights into α-pinene ozonolysis pathways and call for future studies to uncover the detailed mechanisms.


Asunto(s)
Contaminantes Atmosféricos , Ozono , Aerosoles , Monoterpenos Bicíclicos , Monoterpenos
6.
Circ Cardiovasc Qual Outcomes ; 13(10): e006515, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-33012172

RESUMEN

BACKGROUND: Patients with atrial fibrillation and severely decreased kidney function were excluded from the pivotal non-vitamin K antagonist oral anticoagulants (NOAC) trials, thereby raising questions about comparative safety and effectiveness in patients with reduced kidney function. The study aimed to compare oral anticoagulants across the range of kidney function in patients with atrial fibrillation. METHODS AND RESULTS: Using a US administrative claims database with linked laboratory data, 34 569 new users of oral anticoagulants with atrial fibrillation and estimated glomerular filtration rate ≥15 mL/(min·1.73 m2) were identified between October 1, 2010 to November 29, 2017. The proportion of patients using NOACs declined with decreasing kidney function-73.5%, 69.6%, 65.4%, 59.5%, and 45.0% of the patients were prescribed a NOAC in estimated glomerular filtration rate ≥90, 60 to 90, 45 to 60, 30 to 45, 15 to 30 mL/min per 1.73 m2 groups, respectively. Stabilized inverse probability of treatment weighting was used to balance 4 treatment groups (apixaban, dabigatran, rivaroxaban, and warfarin) on 66 baseline characteristics. In comparison to warfarin, apixaban was associated with a lower risk of stroke (hazard ratio [HR], 0.57 [0.43-0.75]; P<0.001), major bleeding (HR, 0.51 [0.44-0.61]; P<0.001), and mortality (HR, 0.68 [0.56-0.83]; P<0.001); dabigatran was associated with a similar risk of stroke but a lower risk of major bleeding (HR, 0.57 [0.43-0.75]; P<0.001) and mortality (HR, 0.68 [0.48-0.98]; P=0.04); rivaroxaban was associated with a lower risk of stroke (HR, 0.69 [0.51-0.94]; P=0.02), major bleeding (HR, 0.84 [0.72-0.99]; P=0.04), and mortality (HR, 0.73 [0.58-0.91]; P=0.006). There was no significant interaction between treatment and estimated glomerular filtration rate categories for any outcome. When comparing one NOAC to another NOAC, there was no significant difference in mortality, but some differences existed for stroke or major bleeding. No relationship between treatments and falsification end points was found, suggesting no evidence for substantial residual confounding. CONCLUSIONS: Relative to warfarin, NOACs are used less frequently as kidney function declines. However, NOACs appears to have similar or better comparative effectiveness and safety across the range of kidney function.


Asunto(s)
Anticoagulantes/administración & dosificación , Antitrombinas/administración & dosificación , Fibrilación Atrial/tratamiento farmacológico , Inhibidores del Factor Xa/administración & dosificación , Tasa de Filtración Glomerular , Riñón/fisiopatología , Insuficiencia Renal Crónica/fisiopatología , Administración Oral , Anciano , Anciano de 80 o más Años , Anticoagulantes/efectos adversos , Antitrombinas/efectos adversos , Fibrilación Atrial/diagnóstico , Fibrilación Atrial/mortalidad , Investigación sobre la Eficacia Comparativa , Dabigatrán/administración & dosificación , Bases de Datos Factuales , Inhibidores del Factor Xa/efectos adversos , Femenino , Hemorragia/inducido químicamente , Humanos , Masculino , Persona de Mediana Edad , Pirazoles/administración & dosificación , Piridonas/administración & dosificación , Insuficiencia Renal Crónica/diagnóstico , Insuficiencia Renal Crónica/mortalidad , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Rivaroxabán/administración & dosificación , Factores de Tiempo , Resultado del Tratamiento , Estados Unidos/epidemiología , Warfarina/administración & dosificación
7.
Chem Commun (Camb) ; 56(67): 9699-9702, 2020 Aug 20.
Artículo en Inglés | MEDLINE | ID: mdl-32699866

RESUMEN

We report a direct C-H aminoalkylation reaction using two light-activated H-atom transfer catalyst systems that enable the introduction of protected amines to native adamantane scaffolds with C-C bond formation. The scope of adamantane and imine reaction partners is broad and deprotection provides versatile amine and amino acid building blocks. Using readily available chiral imines, the enantioselective synthesis of the saxagliptin core and rimantadine derivatives is also described.


Asunto(s)
Aminas/química , Carbono/química , Hidrógeno/química , Luz , Alquilación , Aminoácidos/química , Catálisis , Iminas/química , Estereoisomerismo
8.
J Nat Prod ; 82(2): 417-421, 2019 02 22.
Artículo en Inglés | MEDLINE | ID: mdl-30735390

RESUMEN

Malylglutamate, a newly identified metabolite in earthworms, was synthesized using a traditional peptide coupling approach for assembling the amide from protected malate and glutamate precursors. The proposed structure (1) and a diastereomer were synthesized, but their NMR spectra did not match the natural sample. Further analysis of the natural sample using HMBC spectroscopy suggested an alternative attachment of the malyl moiety, and ß-malylglutamate (2) diastereomers were synthesized, L,L-2 and D,D-2. NMR spectra were an excellent match with the natural sample, and chiral-phase chromatography was employed to identify (-)-ß-l-malyl-l-glutamate (2) as the isomer native to Eisenia fetida.


Asunto(s)
Glutamatos/química , Glutamatos/síntesis química , Oligoquetos/metabolismo , Péptidos/síntesis química , Animales , Glutamatos/metabolismo , Espectroscopía de Resonancia Magnética , Malatos/química , Péptidos/química , Estereoisomerismo
9.
Medchemcomm ; 10(12): 2024-2037, 2019 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-32904148

RESUMEN

Members of the matrix metalloproteinase (MMP) family have biological functions that are central to human health and disease, and MMP inhibitors have been investigated for the treatment of cardiovascular disease, cancer and neurodegenerative disorders. The outcomes of initial clinical trials with the first generation of MMP inhibitors proved disappointing. However, our growing understanding of the complexities of the MMP function in disease, and an increased understanding of MMP protein architecture and control of activity now provide new opportunities and avenues to develop MMP-focused therapies. Natural products that affect MMP activities have been of strong interest as templates for drug discovery, and for their use as chemical tools to help delineate the roles of MMPs that still remain to be defined. Herein, we highlight the most recent discoveries of structurally diverse natural product inhibitors to these proteases.

10.
Org Lett ; 20(19): 6234-6238, 2018 10 05.
Artículo en Inglés | MEDLINE | ID: mdl-30251866

RESUMEN

A synthetic strategy for phenolic lipids such as anacardic acid and ginkgolic acid derivatives using an efficient and selective redox-relay Heck reaction followed by a stereoselective olefination is reported. This approach controls both the alkene position and stereochemistry, allowing the synthesis of natural and unnatural unsaturated lipids as single isomers. By this strategy, the activities of different anacardic acid and ginkgolic acid derivatives have been examined in a matrix metalloproteinase inhibition assay.


Asunto(s)
Ácidos Anacárdicos/síntesis química , Lípidos/síntesis química , Inhibidores de la Metaloproteinasa de la Matriz/síntesis química , Fenoles/química , Salicilatos/síntesis química , Alquenos/química , Estructura Molecular , Oxidación-Reducción , Paladio/química , Estereoisomerismo , Relación Estructura-Actividad
11.
Org Lett ; 20(11): 3151-3155, 2018 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-29781280

RESUMEN

An iterative cross-coupling approach to conjugated trienes was explored as part of a planned stereoselective synthesis of bicyclic terpenes. Using a bifunctional bromoboronate building block, sequential Suzuki coupling reactions were employed to provide a conjugated trienone target containing a tetrasubstituted alkene. During the final cross-coupling step, an unexpected alkene isomerization was observed to give less hindered trans products. Examination of different substrates determined that conjugation to a ketone withdrawing group was responsible for isomerization, rather than steric hindrance of the tetrasubstituted alkene.

12.
Am J Prev Med ; 49(6 Suppl 4): S364-76, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26590436

RESUMEN

Major vaccine safety controversies have arisen in several countries beginning in the last decades of 20th century. Such periodic vaccine safety controversies are unlikely to go away in the near future as more national immunization programs mature with near elimination of target vaccine-preventable diseases that result in relative greater prominence of adverse events following immunizations, both true reactions and temporally coincidental events. There are several ways in which vaccine safety capacity can be improved to potentially mitigate the impact of future vaccine safety controversies. This paper aims to take a "lifecycle" approach, examining some potential pre- and post-licensure opportunities to improve vaccine safety, in both developed (specifically U.S. and Europe) and low- and middle-income countries.


Asunto(s)
Salud Global , Seguridad , Vacunas/efectos adversos , Sistemas de Registro de Reacción Adversa a Medicamentos , Países Desarrollados , Países en Desarrollo , Control de Medicamentos y Narcóticos , Humanos , Programas de Inmunización , Esquemas de Inmunización , Medicina de Precisión , Mujeres Embarazadas , Vigilancia de Productos Comercializados/métodos , Proyectos de Investigación , Medición de Riesgo , Biología de Sistemas
13.
Vaccine ; 33 Suppl 4: D46-54, 2015 Nov 27.
Artículo en Inglés | MEDLINE | ID: mdl-26433922

RESUMEN

Major vaccine safety controversies have arisen in several countries beginning in the last decades of 20th century. Such periodic vaccine safety controversies are unlikely to go away in the near future as more national immunization programs mature with near elimination of target vaccine-preventable diseases that result in relative greater prominence of adverse events following immunizations, both true reactions and temporally coincidental events. There are several ways in which vaccine safety capacity can be improved to potentially mitigate the impact of future vaccine safety controversies. This paper aims to take a "lifecycle" approach, examining some potential pre- and post-licensure opportunities to improve vaccine safety, in both developed (specifically U.S. and Europe) and low- and middle-income countries.


Asunto(s)
Programas de Inmunización , Vacunas/efectos adversos , Sistemas de Registro de Reacción Adversa a Medicamentos , Aprobación de Drogas , Europa (Continente) , Humanos , Concesión de Licencias , Vigilancia de Productos Comercializados , Seguridad , Estados Unidos , Vacunación
14.
Am J Epidemiol ; 181(8): 608-18, 2015 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-25769306

RESUMEN

The Postlicensure Rapid Immunization Safety Monitoring Program, the vaccination safety monitoring component of the US Food and Drug Administration's Mini-Sentinel project, is currently the largest cohort in the US general population for vaccine safety surveillance. We developed a study design selection framework to provide a roadmap and description of methods that may be utilized to evaluate potential associations between vaccines and health outcomes of interest in the Postlicensure Rapid Immunization Safety Monitoring Program and other systems using administrative data. The strengths and weaknesses of designs for vaccine safety monitoring, including the cohort design, the case-centered design, the risk interval design, the case-control design, the self-controlled risk interval design, the self-controlled case series method, and the case-crossover design, are described and summarized in tabular form. A structured decision table is provided to aid in planning of future vaccine safety monitoring activities, and the data components comprising the structured decision table are delineated. The study design selection framework provides a starting point for planning vaccine safety evaluations using claims-based data sources.


Asunto(s)
Inmunización/efectos adversos , Seguridad del Paciente , Vigilancia de Productos Comercializados/métodos , Vacunas/efectos adversos , Estudios de Casos y Controles , Estudios de Cohortes , Humanos , Proyectos de Investigación
15.
PLoS One ; 9(12): e115553, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25536228

RESUMEN

BACKGROUND: Managing emerging vaccine safety signals during an influenza pandemic is challenging. Federal regulators must balance vaccine risks against benefits while maintaining public confidence in the public health system. METHODS: We developed a multi-criteria decision analysis model to explore regulatory decision-making in the context of emerging vaccine safety signals during a pandemic. We simulated vaccine safety surveillance system capabilities and used an age-structured compartmental model to develop potential pandemic scenarios. We used an expert-derived multi-attribute utility function to evaluate potential regulatory responses by combining four outcome measures into a single measure of interest: 1) expected vaccination benefit from averted influenza; 2) expected vaccination risk from vaccine-associated febrile seizures; 3) expected vaccination risk from vaccine-associated Guillain-Barre Syndrome; and 4) expected change in vaccine-seeking behavior in future influenza seasons. RESULTS: Over multiple scenarios, risk communication, with or without suspension of vaccination of high-risk persons, were the consistently preferred regulatory responses over no action or general suspension when safety signals were detected during a pandemic influenza. On average, the expert panel valued near-term vaccine-related outcomes relative to long-term projected outcomes by 3:1. However, when decision-makers had minimal ability to influence near-term outcomes, the response was selected primarily by projected impacts on future vaccine-seeking behavior. CONCLUSIONS: The selected regulatory response depends on how quickly a vaccine safety signal is identified relative to the peak of the pandemic and the initiation of vaccination. Our analysis suggested two areas for future investment: efforts to improve the size and timeliness of the surveillance system and behavioral research to understand changes in vaccine-seeking behavior.


Asunto(s)
Gripe Humana/epidemiología , Gripe Humana/inmunología , Modelos Inmunológicos , Pandemias/prevención & control , Vacunas/efectos adversos , Simulación por Computador , Toma de Decisiones , Síndrome de Guillain-Barré/etiología , Humanos , Gripe Humana/prevención & control , Aceptación de la Atención de Salud , Factores de Riesgo , Convulsiones Febriles/etiología , Factores de Tiempo , Resultado del Tratamiento , Vacunación
16.
Am J Epidemiol ; 178(6): 962-73, 2013 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-23652165

RESUMEN

Given the increased risk of Guillain-Barré Syndrome (GBS) found with the 1976 swine influenza vaccine, both active surveillance and end-of-season analyses on chart-confirmed cases were performed across multiple US vaccine safety monitoring systems, including the Medicare system, to evaluate the association of GBS after 2009 monovalent H1N1 influenza vaccination. Medically reviewed cases consisted of H1N1-vaccinated Medicare beneficiaries who were hospitalized for GBS. These cases were then classified by using Brighton Collaboration diagnostic criteria. Thirty-one persons had Brighton level 1, 2, or 3 GBS or Fisher Syndrome, with symptom onset 1-119 days after vaccination. Self-controlled risk interval analyses estimated GBS risk within the 6-week period immediately following H1N1 vaccination compared with a later control period, with additional adjustment for seasonality. Our results showed an elevated risk of GBS with 2009 monovalent H1N1 vaccination (incidence rate ratio = 2.41, 95% confidence interval: 1.14, 5.11; attributable risk = 2.84 per million doses administered, 95% confidence interval: 0.21, 5.48). This observed risk was slightly higher than that seen with previous seasonal influenza vaccines; however, additional results that used a stricter case definition (Brighton level 1 or 2) were not statistically significant, and our ability to account for preceding respiratory/gastrointestinal illness was limited. Furthermore, the observed risk was substantially lower than that seen with the 1976 swine influenza vaccine.


Asunto(s)
Enfermedades Gastrointestinales/complicaciones , Síndrome de Guillain-Barré/inducido químicamente , Vacunas contra la Influenza/efectos adversos , Gripe Humana/prevención & control , Medicare/estadística & datos numéricos , Enfermedades Respiratorias/complicaciones , Anciano , Femenino , Síndrome de Guillain-Barré/clasificación , Síndrome de Guillain-Barré/epidemiología , Síndrome de Guillain-Barré/etiología , Hospitalización , Humanos , Subtipo H1N1 del Virus de la Influenza A/inmunología , Vacunas contra la Influenza/administración & dosificación , Gripe Humana/inmunología , Revisión de Utilización de Seguros , Masculino , Síndrome de Miller Fisher/inducido químicamente , Síndrome de Miller Fisher/clasificación , Síndrome de Miller Fisher/epidemiología , Síndrome de Miller Fisher/etiología , Distribución de Poisson , Estados Unidos/epidemiología
17.
Science ; 339(6127): 1593-6, 2013 Mar 29.
Artículo en Inglés | MEDLINE | ID: mdl-23539600

RESUMEN

The direct ß-activation of saturated aldehydes and ketones has long been an elusive transformation. We found that photoredox catalysis in combination with organocatalysis can lead to the transient generation of 5π-electron ß-enaminyl radicals from ketones and aldehydes that rapidly couple with cyano-substituted aryl rings at the carbonyl ß-position. This mode of activation is suitable for a broad range of carbonyl ß-functionalization reactions and is amenable to enantioselective catalysis.


Asunto(s)
Aldehídos/química , Cetonas/química , Procesos Fotoquímicos , Catálisis , Oxidación-Reducción
18.
Chem Sci ; 2012(3): 1650-1655, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22611483

RESUMEN

Computational studies show that the base-mediated intramolecular Diels-Alder of tryptamine-derived Zincke aldehydes, used as a key step in the synthesis of the Strychnos alkaloids norfluorocurarine and strychnine, proceeds via a stepwise pathway. The experimentally determined importance of a potassium counterion in the base is explained by its ability to preorganize the Zincke aldehyde diene in an s-cis conformation suitable to bicyclization. Computation also supports the thermodynamic importance of the generation of a stable enolate in the final reaction step. The thermal cycloreversion reaction of the Diels-Alder products is also found to proceed in a stepwise manner.

19.
Vaccine ; 30(18): 2824-30, 2012 Apr 16.
Artículo en Inglés | MEDLINE | ID: mdl-22394993

RESUMEN

Active vaccine safety surveillance systems commonly use computerized diagnostic codes to identify potential health outcomes of interest. Evidence concerning the accuracy of these codes is variable, and few systematic reviews are available. This project's aim was to select a list of health outcomes of interest most suitable for evaluation in the Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring (PRISM) program. We conducted an expert elicitation process to develop the list. A comprehensive list of potential health outcomes of interest was formed based on input from a wide variety of vaccine safety experts. We then selected five panelists with senior leadership roles in vaccine safety from both within and outside the FDA. We elicited the experts' recommendations via a structured, iterative process that included an Internet-assisted telephone conference call and formal voting procedures. The expert panelists identified several criteria as important in their choices, including clinical severity, public health importance, rare or uncommon incidence, relevance to two or more vaccines, and historical association with vaccines. The list of 24 outcomes chosen by the experts and refined by the FDA included ten neurologic outcomes, two circulatory system outcomes, and two musculoskeletal outcomes. The PRISM program plans to conduct a set of evidence reviews on the positive predictive value and other characteristics of existing computerized codes and algorithms to identify these health outcomes of interest.


Asunto(s)
Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/diagnóstico , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/patología , Vigilancia de Productos Comercializados/métodos , Vigilancia de Productos Comercializados/normas , Vacunas/administración & dosificación , Vacunas/efectos adversos , Humanos , Estados Unidos , United States Food and Drug Administration
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...